Workflow
每周股票复盘:维力医疗(603309)产品获加拿大认证,募投项目进展顺利

Core Viewpoint - Vili Medical has received certification for its urological guide wire from the Canadian Ministry of Health, which allows for legal sales in the Canadian market, potentially enhancing overseas market promotion and sales [1][4]. Group 1: Company Announcements - Vili Medical's urological guide wire has been certified as a Class II medical device by the Canadian Ministry of Health, with the certification issued on May 28, 2025 [1][4]. - The company has completed the use of funds raised from its non-public stock issuance in 2021, totaling approximately 399.44 million yuan, with all fundraising accounts now closed [2][4]. - The funds were allocated to various projects, including the construction of a marketing center, production of anti-infection catheters, and the establishment of a research and development center [2]. Group 2: Financial Information - The non-public issuance involved 29,632,218 shares at a price of 13.48 yuan per share, resulting in a net amount of approximately 392.81 million yuan after expenses [2]. - The remaining balance of 2,456.97 yuan from the research and development project has been transferred to supplement working capital, with the project expected to be operational by December 31, 2025 [2].